Galapagos | GLPG - Current Assets



Galapagos reported EUR3.26B in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
argenx SE 5.83B 946.64M Jun/2025
AstraZeneca USD 28.94B 2.8B Jun/2025
Biogen USD 7.97B 341.7M Jun/2025
Genmab DKK 3.91B 127M Jun/2025
Gilead Sciences USD 14.72B 2.18B Jun/2025
GlaxoSmithKline GBP 17.67B 412M Jun/2025
GRIFOLS EUR 5.25B 393.8M Jun/2025
Hikma Pharmaceutical USD 2.26B 22M Dec/2024
Incyte USD 3.64B 411.91M Jun/2025
Merck EUR 12.2B 216M Jun/2025
Neurocrine Biosciences USD 1.75B 111M Jun/2025
Novartis USD 25.94B 831M Jun/2025
Roche Holding CHF 40.04B 6.41B Dec/2024
Sanofi 37.02B 7B Jun/2025
UCB EUR 4.79B 1.47B Dec/2024
Vertex Pharmaceuticals USD 10.43B 419.1M Jun/2025